If you live with COPD and elevated eosinophil counts, you may qualify for a trial evaluating an investigational biologic therapy. The study looks at whether reducing inflammation can improve COPD outcomes.

Highlights:

• For COPD patients with eosinophil count >150
• Standard therapy + investigational drug or placebo
• Ongoing lung function and symptom monitoring
• Compensation provided

Take part in research that may redefine COPD treatment pathways.